Skip to main content
RCEL
NASDAQ Industrial Applications And Services

AVITA 10-Q Details Q3: Revenue $26.1M, Net Loss Narrowed to $6.2M, Going Concern Gone

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$17.7
Mkt Cap
$484.933M
52W Low
$3.22
52W High
$16.9
52W Position info
450% above low
Off High info
at 52W high
Rel. Volume info
1.7× avg
Market data snapshot near publication time

RCEL has more than doubled off its 52-week low of $3.22.

Summary

AVITA's Q3 10-Q confirms 53% revenue growth to $26.1M, an 84.0% gross margin and a narrowed $6.2M net loss, with the going-concern warning formally removed after the final $10.0M credit draw.


Key Events · Earnings and Guidance · RCEL

  • Q3 Revenue Up 53% to $26.1M

    Total revenue rose to $26.1M from $17.1M, with RECELL at $23.1M and Cohealyx at $2.1M; gross margin was 84.0% versus 81.3%.

  • Net Loss Narrowed to $6.2M

    Quarterly net loss fell to $6.2M ($0.20 per share) from $13.2M, and operating loss shrank to $2.6M from $9.2M.

  • Going Concern Warning Removed

    Management concluded substantial doubt no longer exists and reclassified the Perceptive loan to a $45.5M long-term liability.

  • Final $10.0M Tranche Drawn

    The revenue milestone was met and the Additional Commitment Amount was borrowed November 3, 2026, vesting 150,000 Perceptive warrant shares at $3.4019.


Analysis · RCEL · Industrial Applications And Services

The 10-Q puts hard numbers behind this morning's headline beat. Revenue rose 53% to $26.1M and gross margin hit 84.0%, while the quarterly net loss shrank to $6.2M from $13.2M a year ago. More important for the balance sheet, management formally concluded substantial doubt about going concern no longer exists after drawing the final $10.0M credit tranche on November 3, 2026, and reclassified the Perceptive loan to long-term. Cash itself is thin at $10.5M, so the company's solvency now rests on the Q4 cash-flow-breakeven target it reaffirmed.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, RCEL was trading at $17.70 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $484.9M. The 52-week trading range was $3.22 to $16.90. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

RCEL - Latest Insights

RCEL
Nov 16, 2026, 8:08 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $16.20
Real-time Price: $15.95 info
Change: -$0.250 (-2%) info
Market Cap: $502.409M info
RCEL
Nov 05, 2026, 4:10 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $17.91
Real-time Price: $15.95 info
Change: -$1.96 (-11%) info
Market Cap: $502.409M info
RCEL
Nov 05, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $16.65
Real-time Price: $15.95 info
Change: -$0.700 (-4%) info
Market Cap: $502.409M info
RCEL
Aug 18, 2026, 7:45 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $8.50
Real-time Price: $15.95 info
Change: +$7.45 (+88%) info
Market Cap: $502.409M info
RCEL
Aug 11, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $8.20
Real-time Price: $15.95 info
Change: +$7.75 (+95%) info
Market Cap: $502.409M info